Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Pendleton

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Primary Health Care Research & Development|October 19, 2012
Leadership for primary health care researchDavid Pendleton
BMJ (Clinical Research Ed.)|December 7, 2002
Values and leadershipDavid Pendleton, Jennifer King
BMJ (Clinical Research Ed.)|August 21, 2023
Primary and social care funding must increase if the NHS is to recoverDavid Haslam, David Pendleton
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2003
Epitope-enhanced conserved HIV-1 peptide protects HLA-A2-transgenic mice against virus expressing HIV-1 antigenTakahiro Okazaki, C David Pendleton, François Lemonnier, et al.
Journal of Virology|August 22, 2006
Possible therapeutic vaccine strategy against human immunodeficiency virus escape from reverse transcriptase inhibitors studied in HLA-A2 transgenic miceTakahiro Okazaki, Masaki Terabe, Andrew T Catanzaro, et al.
Cancer Research|February 3, 2006
Identification and epitope enhancement of a PAX-FKHR fusion protein breakpoint epitope in alveolar rhabdomyosarcoma cells created by a tumorigenic chromosomal translocation inducing CTL capable of lysing human tumorsLeon T van den Broeke, C David Pendleton, Crystal Mackall, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2006
Epitope enhancement of a CD4 HIV epitope toward the development of the next generation HIV vaccineTakahiro Okazaki, C David Pendleton, Pablo Sarobe, et al.
Plos One|June 11, 2013
Identification and enhancement of HLA-A2.1-restricted CTL epitopes in a new human cancer antigen-POTEYi-Hsiang Huang, Masaki Terabe, C David Pendleton, et al.
Virology|June 20, 2006
Protective immunity provided by HLA-A2 epitopes for fusion and hemagglutinin proteins of measles virusSangKon Oh, Brian Stegman, C David Pendleton, et al.
Cancer Research|April 3, 2004
Human CTLs to wild-type and enhanced epitopes of a novel prostate and breast tumor-associated protein, TARP, lyse human breast cancer cellsSangKon Oh, Masaki Terabe, C David Pendleton, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Primary Health Care Research & Development|October 19, 2012
Leadership for primary health care researchDavid Pendleton
BMJ (Clinical Research Ed.)|December 7, 2002
Values and leadershipDavid Pendleton, Jennifer King
BMJ (Clinical Research Ed.)|August 21, 2023
Primary and social care funding must increase if the NHS is to recoverDavid Haslam, David Pendleton
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2003
Epitope-enhanced conserved HIV-1 peptide protects HLA-A2-transgenic mice against virus expressing HIV-1 antigenTakahiro Okazaki, C David Pendleton, François Lemonnier, et al.
Journal of Virology|August 22, 2006
Possible therapeutic vaccine strategy against human immunodeficiency virus escape from reverse transcriptase inhibitors studied in HLA-A2 transgenic miceTakahiro Okazaki, Masaki Terabe, Andrew T Catanzaro, et al.
Cancer Research|February 3, 2006
Identification and epitope enhancement of a PAX-FKHR fusion protein breakpoint epitope in alveolar rhabdomyosarcoma cells created by a tumorigenic chromosomal translocation inducing CTL capable of lysing human tumorsLeon T van den Broeke, C David Pendleton, Crystal Mackall, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2006
Epitope enhancement of a CD4 HIV epitope toward the development of the next generation HIV vaccineTakahiro Okazaki, C David Pendleton, Pablo Sarobe, et al.
Plos One|June 11, 2013
Identification and enhancement of HLA-A2.1-restricted CTL epitopes in a new human cancer antigen-POTEYi-Hsiang Huang, Masaki Terabe, C David Pendleton, et al.
Virology|June 20, 2006
Protective immunity provided by HLA-A2 epitopes for fusion and hemagglutinin proteins of measles virusSangKon Oh, Brian Stegman, C David Pendleton, et al.
Cancer Research|April 3, 2004
Human CTLs to wild-type and enhanced epitopes of a novel prostate and breast tumor-associated protein, TARP, lyse human breast cancer cellsSangKon Oh, Masaki Terabe, C David Pendleton, et al.
Pageof 2